Abstract
The main difference between macrocyclic Gd-DOTA and linear Gd-DTPA complexes is the greater stability of the former which theoretically might reduce biological interactions in man. To evaluate the clinical relevance of this property, 300 unselected neurological patients were included in a randomised double-blind comparison involving five European centres, focused mainly on the tolerance of these two contrast media. Clinical tolerance was assessed immediatley after the procedure and 24 h later. Adverse events were found with a similar frequency in the two groups (17.3% for Gd-DOTA and 19.3% for Gd-DTPA). Minor neurological symptoms were the most frequent (48.6%) headache being the most common (29.2% of adverse events). No difference in efficacy was found.
Similar content being viewed by others
References
Armitage FE, Richardson DE, Li KCP (1990) Polymeric contrast agents for magnetic resonance imaging: synthesis and characterization of gadolinium diethylenetriaminepenta-acetic acid conjugated to polysaccharides. Bioconj Chem 1: 365–374
Bonnemain B, Lautrou J, Meyer D, Doucet D (1987) Produits de contraste non radiologiques (IRM). In: Amiel M, Ducassou D, Frija G, Grenier P (eds) Medical imaging research. INSERM, Paris, pp 61–67
Brücher E, Lanrenczy G (1981) Aminopolycarboxylates of rare earths. VIII. Kinetic study of exchange reactions between Eu3+ ions and lanthanide (III) diethylenetriaminepentaacetate complexes. J Inorg Nucl Chem 43: 2089–2096
Chang CA (1991) Lanthanide magnetic resonance imaging contrast agents: thermodynamic, kinetic and structural properites of lanthanide (III) macrocyclic complexes. Eur J Solid State Inorg 28: 237–244
Fritz T, Unger E, Wilson-Sanders S, Ahkong QF, Tilcock C (1991) Detailed toxicity studies of liposomal gadolinium DTPA. Invest Radiol 26: 960–968
Golstein H, Kashanian FK, Blumetti RF et al (1990) Safety assessment of gadopentetate dimeglumine in US clinical trials. Radiology 174: 17–23
Haler TJ (1979) Toxicity. In: Gschneider KA Jr, Eyring L (eds) Handbook on the physics and chemistry of rare earths. North Holland, Amsterdam, 40: 553–585
Harbur OL (1991) Generalized seizure after IV administration of gadopentetate dimeglumine. AJNR 12: 666
International application files. International date Larobatoire Guerbet, 1989
Laflore J, Golstein H, Rogan R et al (1989) A prospective evaluation of adverse experiences following the administration of Magnevist (gadopentetate dimeglumine) injection. In: SMRM August 12–18, Amsterdam, p 1067
Lauffer RB (1990) Magnetic resonance contrast media: principles and progress. Magn Reson Q 6: 2: 65–84
Meyer D, Schaefer M, Bonnemain B (1988) Gd-DOTA, a potential MRI contrast agent: current status of physicochemical knowledge. Invest Radiol 23: 232–235
Neiss AC, Le Mignon MM, Vitry A, Caillé JM (1991) Efficacité et tolérance du DOTA-Gd lors d'une unquête multicentrique européenne: résultats préliminaires sur 4169 cas. Rev Im Méd 3: 383–387
Niendorf HP, Dinger JC, Hausteins J et al (1991) Tolerance data of Gd-DTPA: a review. Europ J Radiol 13: 15–20
Salonen ALM (1990) Case of anaphylaxis and four cases of allergic reaction following Gd-DTPA administration. J Comput Assist Tomogr 4: 912–913
Schaefer M, Meyer D, Beauté S, Doucet D (1991) A new macrocyclic MRI contrast agent; Gd-MCTA complex. Magn Reson Med 22: 238–241
Sieving PF, Watson AD, Rocklage SM (1990) Preparation and characterization of paramagnetic polychelates and their protein conjugates. Bioconj Chem 1: 65–71
Tishler S, Hoffman JC (1990) Anaphylactoid reactions to IV gadopentetate dimeglumine. AJNR 11: 1167
Tweedle MR, Hagan JJ, Kumar K, Mantha S, Chang CA (1991) Reaction of gadolinium chelates with endogenously available ions. Magn Reson Imag 9: 409–415
Unger EC, Fritz TA, Tilcock C, New TE (1991) Clearance of liposomal gadolinium: in vivo decomplexation. JMRI 1: 689–693
Weiss KL (1990) Severe anaphylactoid reaction after IV Gd-DTPA. Magn Reson Imag 8: 817–818
Wolf GL (1989) Current status of MRI imaging. Contrast agents: special report. Radiology 172: 709–710
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brugiores, P., Gaston, A., Degryse, H.R. et al. Randomised double blind trial of the safety and efficacy of two gadolinium complexes (Gd-DTPA and Gd-DOTA). Neuroradiology 36, 27–30 (1994). https://doi.org/10.1007/BF00599189
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00599189